4-aminobut-2-yn-1-ol hydrochloride | 39711-80-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 4-aminobut-2-yn-1-ol hydrochloride
• 英文别名: 4-Amino-butin-(2)-ol-(1)*HCl；4-aminobut-2-yn-1-ol;hydrochloride
• CAS: 39711-80-3
• 化学式: C₄H₇NO*ClH
• mdl: MFCD21602644
• 分子量: 121.567
• InChiKey: MGQZIBHXEFVTHC-UHFFFAOYSA-N

物化性质

• 熔点：
  175 °C

计算性质

• 辛醇/水分配系数(LogP)：
  -0.84
• 重原子数：
  7
• 可旋转键数：
  0
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  46.2
• 氢给体数：
  3
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-aminobut-2-yn-1-ol hydrochloride 在 镍 氢气 作用下， 以 水 为溶剂， 生成 4-氨基-1-丁醇
  参考文献：
  名称：

  Marszak-Fleury,A.; Laroche,J., Bulletin de la Societe Chimique de France, 1963, p. 1270 - 1272

  摘要：

  DOI：

文献信息

• Novel substituted triazolo benzodiazepine scaffolds to explore chemical space
  作者：Gayan A. Abeykoon、James J. Sahn、Stephen F. Martin

  DOI：10.1016/j.tetlet.2021.152828

  日期：2021.3

  process to give an intermediate azido alkyne that undergoes a facile Huisgen dipolar cycloaddition. The triazolo-1,4-benzodiazepines thus produced may be endowed with aryl halide, secondary amino, alcohol, aldehyde or carboxylic acid groups as functional handles for orthogonal derivatization reactions. Modification of this approach enabled the facile synthesis of the related triazolo-1,4-benzodiazepin-6-ones

  描述了高效，简明的路线，获取了新颖的三唑并-1,4-苯并二氮杂sc骨架，这些骨架经过适当的官能化处理，可以在三个位置进行多样化，以探索具有不同取代基的三维空间。这些支架的一种方法具有简化的多组分组装过程，可得到中间体叠氮基炔烃，该中间体可进行简单的惠斯根偶极环加成反应。如此产生的三唑并1,4-苯并二氮杂may可被赋予芳基卤，仲氨基，醇，醛或羧酸基团作为正交衍生化反应的功能性处理。对该方法的改进使得可以容易地合成相关的三唑-1,4-苯并二氮杂-6-酮，也带有三个功能性手柄。
• N-substituted paramenthane carboxamides
  申请人：Wilkinson Sword Limited

  公开号：US04150052A1

  公开（公告）日：1979-04-17

  Novel compounds are disclosed having a physiological cooling action on the skin. The compounds are N-substituted p-menthane 3-carboxyamides.

  本发明揭示了一种对皮肤具有生理降温作用的新化合物。这些化合物是N-取代的p-薄荷烷-3-羧酰胺。
• Substituted-acetamide compound and a process for the preparation thereof
  申请人：Fujisawa Pharmaceutical Co., Ltd.

  公开号：US05192779A1

  公开（公告）日：1993-03-09

  Compounds of the formula ##STR1## wherein R.sup.1 is aryl which may have one or more suitable substituent(s) R.sup.2 is aryl which may have one or more suitable substituent(s), lower alkyl or cyclo(lower)alkyl, R.sup.3 is hydrogen, hydroxy, halogen, lower alkenyl, amino or protected amino, R.sup.4 is a group of the formula: ##STR2## wherein R.sup.5 is lower alkyl which may have one or more suitable substituent(s), cyclo(lower)alkyl, aryl, ar(lower)alkyl which may have one or more suitable substituent(s), and R.sup.6 is hydrogen or lower alkyl; or N-containing heterocyclic group which may have one or more suitable substituent(s), and A is lower alkylene or lower alkynylene, in which R.sup.1 and R.sup.2 may be linked through an oxygen atom, their preparation and use in treatment of dysuria, and starting materials for their preparation.

  本发明涉及一种化合物，其分子式为##STR1##其中，R.sup.1是芳基，可能具有一个或多个适当的取代基；R.sup.2是芳基，可能具有一个或多个适当的取代基，较低烷基或环状（较低）烷基；R.sup.3是氢、羟基、卤素、较低烯基、氨基或保护氨基；R.sup.4是以下式的基团：##STR2##其中，R.sup.5是较低烷基，可能具有一个或多个适当的取代基，环状（较低）烷基、芳基、ar（较低）烷基，可能具有一个或多个适当的取代基，R.sup.6是氢或较低烷基；或含氮杂环基团，可能具有一个或多个适当的取代基；A是较低的烷基或较低的炔基，在其中R.sup.1和R.sup.2可以通过氧原子连接。本发明还涉及其制备方法、用于治疗尿路疾病的用途以及其制备的起始材料。
• Novel substituted-acetamide compound and a process for the preparation
  申请人：Fujisawa Pharmaceutical Co., Ltd.

  公开号：US05066680A1

  公开（公告）日：1991-11-19

  Compounds of the formula ##STR1## wherein R.sup.1 is aryl which may have one or more suitable substituent(s), R.sup.2 is aryl which may have one or more suitable substituent(s), lower alkyl or cyclo(lower)alkyl, R.sup.3 is hydrogen, hydroxy, halogen, lower alkenyl, amino or protected amino, R.sup.4 is a group of the formula: ##STR2## wherein R.sup.5 is lower alkyl which may have one or more suitable substituent(s), cyclo(lower)alkyl, aryl, ar(lower)alkyl which may have one or more suitable substituent(s), and R.sup.6 is hydrogen or lower alkyl; or N-containing heterocyclic group which may have one or more suitable substituent(s), and A is lower alkylene or lower alkynylene, in which R.sup.1 and R.sup.2 may be linked through oxygen atom, their preparation and use in treatment of dysuria, and starting materials for their preparation.

  该化合物的分子式为##STR1##其中R.sup.1是芳基，可能有一个或多个适当的取代基，R.sup.2是芳基，可能有一个或多个适当的取代基，较低烷基或环状（较低）烷基，R.sup.3是氢、羟基、卤素、较低烯基、氨基或保护氨基，R.sup.4是以下公式的一组：##STR2##其中R.sup.5是较低烷基，可能有一个或多个适当的取代基，环状（较低）烷基，芳基，ar（较低）烷基，可能有一个或多个适当的取代基，R.sup.6是氢或较低烷基；或含N的杂环基，可能有一个或多个适当的取代基，A是较低烷基或较低炔基，在其中R.sup.1和R.sup.2可以通过氧原子连接，其制备和用于治疗排尿困难症的用途，以及其制备的起始材料。
• S-adenosyl-L-methionine analogs with extended activated groups for transfer by methyltransferases
  申请人：RWTH Aachen

  公开号：US08008007B2

  公开（公告）日：2011-08-30

  S-Adenosyl-L-methionine analogs of formula (I): are disclosed wherein R comprises a carbon-carbon double bond, carbon-sulfur double bond, carbon-nitrogen double bond, -a carbon-carbon triple bond, carbon-nitrogen triple bond or an aromatic carbocyclic or heterocyclic system in β-position to the sulfonium center, Xcircle around (−)} is an organic or inorganic anion carrying one or more negative charges, Z is —CR1R2—, —O—, —S— or —NR3— and R1, R2 and R3 are independently selected from H, D and C1—C alkyl; as well as complexes with a methyltransferase, pharmaceutical compositions, methods for modifying a biomolecule, and methods for detecting sequences specific methylation of biomolecules.

  公开了化学式（I）的S-腺苷基-L-甲硫氨酸类似物，其中R包括碳-碳双键，碳-硫双键，碳-氮双键，碳-碳三键，碳-氮三键或位于磺酸中心的β位的芳香族碳环或杂环系统，X circle around (-)}是携带一个或多个负电荷的有机或无机阴离子，Z是-CR1R2-，-O-，-S-或-NR3-，其中R1，R2和R3独立选择自H，D和C1-C烷基；以及与甲基转移酶的复合物，制备修饰生物分子的药物组合物，检测特定甲基化生物分子序列的方法。